Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of VAP-1 Expression and Tissue Blood Flow by Combined [68Ga]DOTA-Siglec-9 and [15O]H2O PET-MRI in Patients With Small Bowel's Crohn's Disease

NCT06555042 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.

NCT NCT06555042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06555042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of VAP-1 Expression and Tissue Blood Flow by Combined [68Ga]DOTA-Siglec-9 and [15O]H2O PET-MRI in Patients With Small Bowel's Crohn's Disease
Lead sponsor
Turku University Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2024
Completion date
June 6, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn colitis, crohn disease, crohn disease in remission, crohn disease of small intestine, crohn's ileocolitis, inflammatory bowel diseases